Summary
The loss of tissue is still one of the most challenging problems in healthcare. Efficient laboratory expansion of skin tissue to reproduce the skins barrier function can make the difference between life and death for patients with extensive full-thickness burns, chronic wounds, or genetic disorders such as bullous conditions. This engineering has been initiated based on the acute need in the 1980s and today, tissue-engineered skin is the reality. The human skin equivalents are available not only as models for permeation and toxicity screening, but are frequently applied in vivo as clinical skin substitutes. This review aims to introduce the most important recent development in the extensive field of tissue engineering and to describe already approved, commercially available skin substitutes in clinical use.
Similar content being viewed by others
References
Zanger P. Staphylococcus aureus positive skin infections and international travel. Wien Klin Wochenschr. 2010;122(1):31–3.
Papini R. ABC of burns—management of burn injuries of various depths. Brit Med J. 2004;329(7458):158–60.
Miller SJ, Burke EM, Rader MD, Coulombe PA, Lavker RM. Re-epithelialization of porcine skin by the sweat apparatus. J Invest Dermatol. 1998;110(1):13–9.
Carter MJ, Tingley-Kelley K, Warriner RA III. Silver treatments and silver-impregnated dressings for the healing of leg wounds and ulcers: a systematic review and meta-analysis. J Am Acad Dermatol. 2010;63(4):668–79.
Pivec T, Peršin Z, Kolar M, Maver T, Dobaj A, Vesel A, Maver U, Stana-Kleinschek K. “Modification of cellulose non-woven substrates for preparation of modern wound dressings, ” Text Res J. 2014;84(1):96–112.
Hackl F, Kiwanuka E, Philip J, Gerner P, Aflaki P, Diaz-Siso JR, Sisk G, Caterson EJ, Junker JP, Eriksson E. Moist dressing coverage supports proliferation and migration of transplanted skin micrografts in full-thickness porcine wounds. Burns. 2014;40(2):274–80.
Ovington LG. Wound care products: how to choose. Home Healthc Nurse. 2001;19(4):224–31.
Tan A, Gollop ND, Klimach SG, Maruthappu M, Smith SF. Should infected laparotomy wounds be treated with negative pressure wound therapy? Int J Surg. 2014;12(1):26–9.
Reed S, Wu B. Sustained growth factor delivery in tissue engineering applications. Ann Biomed Eng. 2014;42(7):1528–36.
Blitterswijk CAv, Thomsen P. Tissue engineering. London: Academic Press; 2008.
Davis JS. Address of the president: the story of plastic surgery. Ann Surg. 1941;113(5):641–56.
Akan M, Yildirim S, Misirlioglu A, Ulusoy G, Akoz T, Avci G. An alternative method to minimize pain in the split-thickness skin graft donor site. Plast Reconstr Surg. 2003;111(7):2243–9.
Andreassi A, Bilenchi R, Biagioli M, D’Aniello C. Classification and pathophysiology of skin grafts. Clin Dermatol. 2005;23(4):332–7.
Hermans MH. Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: is there a clinical difference? Burns. 2014;40(3):408–15.
Langdon RC, Cuono CB, Birchall N, Madri JA, Kuklinska E, McGuire J, Moellmann GE. Reconstitution of structure and cell function in human skin grafts derived from cryopreserved allogeneic dermis and autologous cultured keratinocytes. J Invest Dermatol. 1988;91(5):478–85.
Langer R, Vacanti JP. Tissue engineering. Science. 1993;260(5110):920–6.
Shevchenko RV, James SL, James SE. A review of tissue-engineered skin bioconstructs available for skin reconstruction. J R Soc Interface. 2010;7(43):229–58.
Sabolinski ML, Alvarez O, Auletta M, Mulder G, Parenteau NL. Cultured skin as a ‘smart material’ for healing wounds: experience in venous ulcers. Biomaterials. 1996;17(3):311–20.
Groeber F, Holeiter M, Hampel M, Hinderer S, Schenke-Layland K. Skin tissue engineering–in vivo and in vitro applications. Clin Plast Surg. 2012;39(1):33–58.
Lazic T, Falanga V. Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg. 2011;127 Suppl 1:75S–90S.
Chester DL, Balderson DS, Papini RP. A review of keratinocyte delivery to the wound bed. J Burn Care Rehabil. 2004;25(3):266–75.
Green H, Kehinde O, Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci. 1979;76(11):5665–8.
Notara M, Bullett NA, Deshpande P, Haddow DB, MacNeil S, Daniels JT. Plasma polymer coated surfaces for serum-free culture of limbal epithelium for ocular surface disease. J Mater Sci Mater Med. 2007;18(2):329–38.
Gallico GG III, O’Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med. 1984;311(7):448–51.
Odessey R. Addendum: multicenter experience with cultured epidermal autograft for treatment of burns. J Burn Care Rehabil. 1992;13(1):174–80.
Williamson JS, Snelling CF, Clugston P, Macdonald IB, Germann E. Cultured epithelial autograft: five years of clinical experience with twenty-eight patients. J Trauma. 1995;39(2):309–19.
MacNeil S. Progress and opportunities for tissue-engineered skin. Nature. 2007;445(7130):874–80.
Andree C, Reimer C, Page CP, Slama J, Stark BG, Eriksson E. Basement membrane formation during wound healing is dependent on epidermal transplants. Plast Reconstr Surg. 2001;107(1):97–104.
Wood FM, Kolybaba ML, Allen P. The use of cultured epithelial autograft in the treatment of major burn injuries: a critical review of the literature. Burns. 2006;32(4):395–401.
Ronfard V, Rives JM, Neveux Y, Carsin H, Barrandon Y. Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation. 2000;70(11):1588–98.
Hernon CA, Dawson RA, Freedlander E, Short R, Haddow DB, Brotherston M, MacNeil S. Clinical experience using cultured epithelial autografts leads to an alternative methodology for transferring skin cells from the laboratory to the patient. Regen Med. 2006;1(6):809–21.
Damanhuri M, Boyle J, Enoch S. Advances in tissue-engineered skin substitutes. Wounds Int. 2011;2(1):4.
Huang S, Xiaobing F. Tissue-engineered skin: bottleneck or breakthrough. Int J Burns Trauma. 2011;1(1):10.
Orgill DP, Butler C, Regan JF, Barlow MS, Yannas IV, Compton CC. Vascularized collagen-glycosaminoglycan matrix provides a dermal substrate and improves take of cultured epithelial autografts. Plast Reconstr Surg. 1998;102(2):423–9.
Rehim SA, Singhal M, Chung KC. Dermal skin substitutes for upper limb reconstruction: current status, indications, and contraindications. Hand Clin. 2014;30(2):239–52,vii.
Lattari V, Jones LM, Varcelotti JR, Latenser BA, Sherman HF, Barrette RR. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases. J Burn Care Rehabil. 1997;18(2):147–55.
Shakespeare PG. The role of skin substitutes in the treatment of burn injuries. Clin Dermatol. 2005;23(4):413–8.
Callcut RA, Schurr MJ, Sloan M, Faucher LD. Clinical experience with alloderm: a one-staged composite dermal/epidermal replacement utilizing processed cadaver dermis and thin autografts. Burns. 2006;32(5):583–8.
Macleod T, Williams G, Sanders R, Green C. Histological evaluation of Permacol as a subcutaneous implant over a 20-week period in the rat model. Br J Plast Surg. 2005;58(4):518–32.
Yannas I, Burke J, Orgill D, Skrabut E. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science. 1982;215(4529):174–6.
Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J, Jordan M, McManus W, Solem L, Warden G, et al. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg. 1988;208(3):313–20.
Anthony ET, Syed M, Myers S, Moir G, Navsaria H. The development of novel dermal matrices for cutaneous wound repair. Drug Discov Today: Ther Strateg. 2006;3(1):81–6.
Cooper ML, Hansbrough JF, Polarek JW. The effect of an arginine-glycine-aspartic acid peptide and hyaluronate synthetic matrix on epithelialization of meshed skin graft interstices. J Burn Care Rehabil. 1996;17(2):108–16.
Hansbrough JF, Boyce ST, Cooper ML, Foreman TJ. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA. 1989;262(15):2125–30.
Gravante G, Delogu D, Giordan N, Morano G, Montone A, Esposito G. The use of Hyalomatrix PA in the treatment of deep partial-thickness burns. J Burn Care Res. 2007;28(2):269–74.
Kempf M, Miyamura Y, Liu PY, Chen AC, Nakamura H, Shimizu H, Tabata Y, Kimble RM, McMillan JR. A denatured collagen microfiber scaffold seeded with human fibroblasts and keratinocytes for skin grafting. Biomaterials. 2011;32(21):4782–92.
Lal S, Barrow RE, Wolf SE, Chinkes DL, Hart DW, Heggers JP, Herndon DN. Biobrane improves wound healing in burned children without increased risk of infection. Shock. 2000;14(3):314–8. (discussion 318–9).
Supp DM, Boyce ST. Engineered skin substitutes: practices and potentials. Clin Dermatol. 2005;23(4):403–12.
Wilkins LM, Watson SR, Prosky SJ, Meunier SF, Parenteau NL. Development of a bilayered living skin construct for clinical applications. Biotechnol Bioeng. 1994;43(8):747–56.
Griffiths M, Ojeh N, Livingstone R, Price R, Navsaria H. Survival of Apligraf in acute human wounds. Tissue Eng. 2004;10(7/8):1180–95.
Still J, Glat P, Silverstein P, Griswold J, Mozingo D. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns. 2003;29(8):837–41.
El-Ghalbzouri A, Lamme EN, van Blitterswijk C, Koopman J, Ponec M. The use of PEGT/PBT as a dermal scaffold for skin tissue engineering. Biomaterials. 2004;25(15):2987–96.
Uccioli L. A clinical investigation on the characteristics and outcomes of treating chronic lower extremity wounds using the tissuetech autograft system. Int J Low Extrem Wounds. 2003;2(3):140–51.
Wood FM, Stoner ML, Fowler BV, Fear MW. The use of a non-cultured autologous cell suspension and Integra® dermal regeneration template to repair full-thickness skin wounds in a porcine model: a one-step process. Burns. 2007;33(6):693–700.
Compton CC, Butler CE, Yannas IV, Warland G, Orgill DP. Organized skin structure is regenerated in vivo from collagen-GAG matrices seeded with autologous keratinocytes. J Invest Dermatol. 1998;110(6):908–16.
Stein E, Blaimauer K, Bauer S, Erovic BM, Turhani D, Thurnher D. High expression of integrin β1 correlates with high proliferation capacity in oral keratinocytes. Wien Klin Wochenschr. 2007;119(9–10):318–22.
Stein E, Koehn J, Sutter W, Wendtlandt G, Wanschitz F, Thurnher D, Baghestanian M, Turhani D. Initial effects of low-level laser therapy on growth and differentiation of human osteoblast-like cells. Wien Klin Wochenschr. 2008;120(3–4):112–7.
Vesenjak M, Matela J, Young P, Said R, Ren Z. Imaging, virtual reconstruction and computational material (tissue) testing. Acta Medico-Biotehnica. 2009;2:19–30.
Tonello C, Vindigni V, Zavan B, Abatangelo S, Abatangelo G, Brun P, Cortivo R. In vitro reconstruction of an endothelialized skin substitute provided with a microcapillary network using biopolymer scaffolds. FASEB J. 2005;19(11):1546–8.
Chen M, Przyborowski M, Berthiaume F. Stem cells for skin tissue engineering and wound healing. Crit Rev Biomed Eng. 2009;37(4–5):399–421.
Furumoto T, Ozawa N, Inami Y, Toyoshima M, Fujita K, Zaiki K, Sahara S, Akita M, Kitamura K, Nakaoji K, Hamada K, Tamai K, Kaneda Y, Maeda A. Mallotus philippinensis bark extracts promote preferential migration of mesenchymal stem cells and improve wound healing in mice. Phytomedicine. 2014;21(3):247–53.
Plikus MV, Gay DL, Treffeisen E, Wang A, Supapannachart RJ, Cotsarelis G. Epithelial stem cells and implications for wound repair. Semin Cell Dev Biol. 2012;23(9):946–53.
Acknowledgements
The paper was co-produced within the framework of the operation entitled “Centre of Open innovation and ResEarch UM (CORE@UM)”. The operation is co-funded by the European Regional Development Fund and conducted within the framework of the Operational Program for Strengthening Regional Development Potentials for the period 2007–2013, development priority 1: “Competitiveness of companies and research excellence”, priority axis 1.1: “Encouraging competitive potential of enterprises and research excellence”, contact No. 3330-13-500032. The authors also acknowledge the financial support from the Ministry of Higher Education, Science and Technology of the Republic of Slovenia, as well as the financial contributions from the mnt-era.net funded project WoundSens with the grant number 3211-12-00002.
Conflict of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maver, T., Maver, U., Kleinschek, K. et al. Advanced therapies of skin injuries. Wien Klin Wochenschr 127 (Suppl 5), 187–198 (2015). https://doi.org/10.1007/s00508-015-0859-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-015-0859-7